SMSirona Medical Financial Model
Health-tech Startup Financials (Free Excel Download)
Sirona is building a unified cloud SaaS platform replacing fragmented on-prem Radiology IT (PACS, RIS, viewer, reporter, worklist) for US radiology practices.
professionals from Deloitte
Used by professionals from
About this model
Sirona Medical is building cloud SaaS to replace fragmented radiology IT such as PACS, RIS, viewers, reporting, and worklists. Its unified workflow targets radiology practices seeking to move away from disconnected on-premise systems and improve how clinicians access and manage imaging work.
It targets US radiology practices, where enterprise deployments can expand through radiologists, sites, studies, and additional workflow modules. Commercial performance depends on long implementation cycles, successful integrations, clinician adoption, cloud reliability, and retention in a mission-critical operational system.
The model forecasts practice customers, radiologist seats or studies, ACV, implementation, expansion, churn, and cloud-support cost. It includes integration services, enterprise sales, customer success, product engineering, gross margin, operating cash flow, cash burn, and runway.
A turnkey financial model
Live formulas, no hardcoded values
Outputs are driven by live formulas, so the workbook updates from its assumptions instead of relying on hardcoded results.
All assumptions in one tab
Inputs are clearly marked in the Assumptions tab and separated from calculations, making it clear what to change and what to leave intact.
Statements always balancing
For integrated-statement models, the balance sheet, cash flow, and supporting schedules tie through properly.
Distinct schedules for clarity
Debt, working capital, taxes, and cash flow can get messy quickly. We group calculations in clear schedules, not across disconnected tabs.
No hidden macros or external links
There are no unexplained external workbook links or macros to undermine auditability or portability.
Changes flow through the model
Update a key driver and see the impact carry through the forecast, financing, and return outputs. We never use hardcoded numbers in formulas.
About Sirona Medical
How to build a detailed financial model for Sirona Medical
A complete walkthrough of the business, drivers, and assumptions behind the downloadable Sirona Medical model - distilled from its pitch deck and publicly available information.
Product & value proposition
- Three-tier subscription platform marketed as "Unify. Simplify. Amplify.":
- Unify (Bronze): Core workflow solution - Viewer, Reporter, Universal Worklist, DICOM Router, HL7 Router. Deployed as overlay on existing on-prem infrastructure; displaces existing RadIT spend. Live in clinical production at time of deck. Target: net savings vs. current fragmented spend.
- Simplify (Silver): Intelligence Amplification (IA) features, premium workflow tools, Communications Hub. Priced at parity with existing spend. Rollout: "next 12 months" from deck date.
- Amplify / RadOS (Gold): Multimedia reports, patient/referring-physician portals, practice management tools, PACS archive, 3rd-party AI integrations, billing & payroll add-ons. Priced to value; rollout 2022–2023.
- Value proposition: replace >80% of healthcare data infrastructure (radiology) with a single cloud platform; improve radiologist productivity and reduce burnout; enable differentiated work products.
Market
- US radiology spend: $110B domestic; 600M annual US exams.
- Radiology sits upstream of 70% of all clinical episodes.
- 50% of US radiology is private practice.
- SOM: $1.5B - US Radiology IT Market (existing RadIT spend: Simplify + Archive).
- SAM: $5.0B - US "RadOS" Market (Amplify package + add-ons).
- TAM: $50B+ - Global RadIT including billing and international expansion; global market 4–5x US market.
- Sirona's current penetration: "Unifying 2% of US Radiologists".
Revenue model
- Model: Per-exam SaaS subscription fee across ~600M domestic annual exams.
- Tiers:
- Unify (Bronze): base platform - priced for net savings vs. incumbent spend.
- Simplify (Silver): workflow/IA premium - priced at parity with existing spend (2022 rollout per deck).
- Amplify (Gold): RadOS practice-differentiation tier - priced to value (2023 rollout per deck).
- Add-on revenue: API layer enabling 3rd-party AI, billing & payroll, prior auth & compliance, portal add-ons.
- Channel: Direct to private radiology practices (initial market); teleradiology networks likely next.
Traction & metrics
- Raised $23M to date as of deck date; in stealth mode.
- Founded 2018 out of Stanford AIMI / BMIR; Series A investors include 8VC, GFC, Xf, Arthur Patterson (Accel founder), Kenan Turnacioglu (Paige AI), Kenneth Heithoff (CDI founder).
- Product live in clinical production - Unify tier.
- Currently unifying "2% of US Radiologists" - no absolute customer count or revenue figure given.
- No ARR, MRR, or revenue figures disclosed (deck explicitly states "in stealth").
Competition / moat
- Competitive framing: incumbents are on-prem, fragmented, built piecemeal; cannot be modernized incrementally.
- Sirona's moat narrative - four pillars of competitive advantage (named but not detailed in extracted text); proprietary data from unified platform enables IA features; patents pending on IA features.
- Named competitors: not explicitly listed; implied incumbents are legacy PACS/RIS/viewer vendors (e.g., Intelerad, CDI / R2 Technology referenced via advisors).
- Overlay deployment strategy avoids "rip and replace" - lowers switching cost barrier.
Team & funding ask / use of funds
- Team: Cameron Andrews (Founder & CEO), Dr. Alan Kaye MD (CMO), Dr. Mark Longo PhD (CTO), Dr. David Paik PhD (CSO), Fred Ong (CFO), Vincenzo Ampollo (Head of Engineering), Tom Pacenta (VP Sales), Dr. Ruggero Tacchi PhD (Head of AI Engineering), Michael Chang (Head of Marketing), Jeremy Koscielny (Head of Implementation).
- Advisors: Jonathan Bush (athenahealth founder), Ron Paulus (ex-CEO Mission Health), Robert Baumgartner (ex-CEO CDI), John Pavlidis (ex-CEO R2 Technology), Jeffrey Queisser (Co-Founder/EVP Eng Box), Curtis Langlotz MD (Stanford AI in Medicine), Chris Wood (ex-CTO Intelerad), Luke Oakden-Rayner (Royal Adelaide Medical Imaging Research).
- Ask: $40M Series B.
- Use of funds: "Unify Radiology onto a Single Defensible Platform" - no itemized breakdown in deck.
- Total raised to date: $23M; $40M ask brings total to ~$63M post-close.
Recommended financial model
- Archetype + why: B2B SaaS per-exam volume model with tiered ARPU expansion. Revenue = exams under management × per-exam fee, blended across tiers as customers upgrade Bronze → Silver → Gold. This matches the stated pricing mechanic ("per-exam fee on ~600M domestic annual exams") and tiered upsell motion. Secondary add-on revenue stream from API layer.
- Forecast horizon & granularity: 5 years (Year 1–5), monthly for Year 1–2 (cash management matters at pre-revenue/early-revenue stage), annual thereafter. Break out by tier.
- Key drivers & assumptions:
- Total addressable exams (US): 600M/year
- Initial target market: private practice (~50% of US radiology = ~300M exams)
- Current penetration: 2% of US radiologists; convert to exam-share
- Unify (Bronze) per-exam fee:
- Simplify (Silver) per-exam fee premium:
- Amplify (Gold) per-exam fee premium:
- Tier mix / upgrade curve:
- Practice acquisition (new logos/month):
- Average exams per practice:
- Gross margin:
- S&M as % of revenue:
- R&D as % of revenue:
- Net burn / runway:
- Churn:
- Scenarios (Base / Bull / Bear - which variables flex):
- Bear: slower practice acquisition (long sales cycles, regulatory friction); Bronze-only pricing; higher churn than expected post-stealth launch.
- Base: per-deck trajectory - Unify deployed, Silver/Gold rolling out Y2–Y3; 2% → 10–15% private practice penetration by Y5.
- Bull: rapid Silver/Gold upgrade; API add-on revenue materializes early; teleradiology network wins (large volume contracts).
- Required sheets / outputs:
- Assumptions (all drivers toggleable)
- Revenue build: exams under mgmt × per-exam fee by tier; add-on revenue
- P&L (GAAP): Revenue, COGS, Gross Profit, S&M, R&D, G&A, EBITDA, Net Income
- Headcount plan (given 10-person exec team + hiring with $40M)
- Cash flow & runway (13-week near-term + annual)
- Market penetration waterfall (exams TAM → SAM → SOM → captured)
- Sensitivity table: per-exam ARPU × exam volume / penetration rate → ARR
- Dashboard: ARR, exams under management, blended ARPU, gross margin, cash runway
Frequently asked
Is the Sirona Medical financial model free?+
Yes. The Sirona Medical model is a free Excel (.xlsx) download with live formulas. Sign up with your email and the workbook is yours to keep, review, and edit.
What's included in the model?+
A 5-year monthly forecast with P&L, cash flow and runway, valuation (exit multiple plus a DCF cross-check), MOIC/IRR returns, and unit economics, with live formulas throughout.
How was this model built?+
It was built from Sirona Medical's pitch deck and publicly available information, then structured to investment-banking standards as a fully editable Excel model.
Can I change the assumptions?+
Yes. You can change assumptions and the live formulas will recalculate in the downloadable Excel model.
Have more financial modelling questions? Contact us
Created by ex-finance professionals
Hey, I’m Alex and I created Finamodel.
Over my years in the finance industry I kept building the same models over and over again. Same structure, same assumptions, different logo. So I started building frameworks to turn them into clean, reusable templates.
Every model here is one I’d actually use for a client, and I personally vet each one before it goes up.
I’m not an expert in every industry, but I’ve built enough models to know what belongs in one. And when something is completely foreign to me, I reach out to my network for experts to work on our models with us.
Having a template library on hand cuts a first build from hours to minutes.
Need help finding your model? You’ll find me in the Finamodel app!
Other Health-tech Startup Financial Models
Browse another startup in the same category.
98point6
B2B SaaS platform licensing an AI-powered virtual care technology stack to health systems, pivoted from running a direct-to-employer virtual clinic.
A-Champs
IoT-powered gamified training device (ROXs PRO) for sports/health professionals, evolving into a B2C smart coach app for families.
AccuRx
Patient-centred communication platform connecting everyone involved in a patient's care, starting with near-universal penetration in UK GP practices.
Aeris
Swiss-made premium air purifiers sold through DTC, retail, and dealer channels, with a recurring filter consumable attached to a connected mobile app.
Akido Labs
Akido Labs is a data-driven prevention platform that integrates siloed healthcare, municipal, and non-profit data to enable proactive outreach and case management for vulnerable populations (homeless, chronically ill, etc.).
Alloy
Telehealth + DTC subscription platform delivering menopause hormonal treatment (MHT) and holistic care to U.S. women 40+.
Astek Diagnostics
Point-of-care diagnostic device (Jiddu system) that confirms bacterial infections and antibiotic sensitivity in ~1 hour across four body fluid types (urine, CSF, effluent, blood).
Atom Limbs
Atom Limbs is building the first AI-powered, neural-controlled prosthetic arm sold direct-to-consumer on a subscription model.
